Tue, October 17, 2017
Mon, October 16, 2017
Fri, October 13, 2017
Thu, October 12, 2017
Wed, October 11, 2017
Tue, October 10, 2017
Mon, October 9, 2017
Fri, October 6, 2017
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017

Charles Duncan Initiated (ALT) at Buy and Held Target at $180 on, Oct 9th, 2017


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-180-on-oct-9th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Charles Duncan of Piper Sandler, Initiated "Altimmune, Inc." (ALT) at Buy and Held Target at $180 on, Oct 9th, 2017.

Charles, nor any peers, have made any analyst calls on ALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources